Gerald P. Linette - Researcher Profile

Publications

3 shown

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi , Steven O’Day , David F. McDermott +26 more

Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma. Adverse eve...

2010 New England Journal of Medicine 14794 citations

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Jeffrey S. Weber , Sandra P. D’Angelo , David R. Minor +25 more

2015 The Lancet Oncology 2617 citations

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Michael A. Postow , Jason Chesney , Anna C. Pavlick +18 more

The objective-response rate and the progression-free survival among patients with advanced melanoma who had not previously received treatment were significantly greater with niv...

2015 New England Journal of Medicine 2716 citations

Frequent Co-Authors

Robert Weber

Jeffrey A. Sosman

Vanderbilt University Medical Center

John B.A.G. Haanen

The Netherlands Cancer Institute

Researcher Info

h-index: 3
Publications: 3
Citations: 20,127
Institution: Washington University in St. Louis

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-6147-6115

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.